Neutrophil-to-lymphocyte : a useful biomarker for predicting severity in coronavirus disease-2019 (COVID19)
W. Jelassi (Nabeul, Tunisia), N. Abid (Nabeul, Tunisia), M. Loukil (Nabeul, Tunisia), N. Gader (Nabeul, Tunisia), M. Ben Ali (Nabeul, Tunisia), I. Chaabane (Nabeul, Tunisia), K. Bouzaidi (Nabeul, Tunisia), H. Ghrairi (Nabeul, Tunisia)
Source: International Congress 2022 – Biomarkers in COVID
Session: Biomarkers in COVID
Session type: Thematic Poster
Number: 342
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Jelassi (Nabeul, Tunisia), N. Abid (Nabeul, Tunisia), M. Loukil (Nabeul, Tunisia), N. Gader (Nabeul, Tunisia), M. Ben Ali (Nabeul, Tunisia), I. Chaabane (Nabeul, Tunisia), K. Bouzaidi (Nabeul, Tunisia), H. Ghrairi (Nabeul, Tunisia). Neutrophil-to-lymphocyte : a useful biomarker for predicting severity in coronavirus disease-2019 (COVID19). 342
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|